Novel acid labile COL1 trityl-linked difluoronucleoside immunoconjugates: Synthesis, characterization, and biological activity

Bioconjugate Chemistry

Volumn 7, Issue 4, 1996, Pages 497-510

  Patel, Vinod F ^a   Hardin, Julie N ^a   Mastro, John M ^a   Law, Kevin L ^a   Zimmermann, John L ^a   Ehlhardt, William J ^a   Woodland, Joseph M ^a   Starling, James J ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOACTIVITY; DRUG DOSAGE; DRUG PRODUCTS; MAMMALS; METABOLITES; PLASMA STABILITY; TUMORS;

ACID-LABILE; ANTITUMOUR ACTIVITY; CARDIOTOXICITY; CLINICAL UTILITY; DIFLUORINATED; DRUG CANDIDATES; HUMAN TUMORS; IMMUNOCONJUGATE; IN-VIVO; TUMOUR XENOGRAFTS;

ANTIGENS;

ANIMALIA; MUS MUSCULUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 0030198183     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc960038u     Document Type: Article

References (53)

1. Foye, W. O., Ed. (1995) Cancer Chemotherapeutic Agents, American Chemical Society, Washington, DC.
2. (a) Bundgaard, H., Ed. (1985) Design of Prodrugs, Elsevier Science, Amsterdam.
3. (b) Roche, E. B., Ed. (1977) Design of Biopharmaceutical Properties through Prodrugs and Analogues, American Pharmaceutical Association, Washington, DC.
4. (c) Stella, V. J., Mikkelson, T. J., and Pipkin, J. D. (1980) Drug Delivery Systems (Juliano, R. L., Ed.) p 112, Oxford University Press, Oxford.
5. (d) Senter, P. D. (1990) Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy. FASEB J. 4, 188-193.
6. (a) Baldwin, R. W. (1985) Monoclonal Antibody Targeting of Anticancer Agents: Muhlbock Memorial Lecture. Eur. J. Cancer Clin. Oncol. 21 (11), 1281-1285.
7. (b) Reisfeld, R. A., and Cherish, D. A. (1985) Human tumor-associated antigens: targets for monoclonal antibody-mediated cancer therapy. Cancer Surv. 4 (1), 271-290.
8. (c) Ghose, T. I., Blair, A. H., Vaughan, K., Kulkarni, P. (1983) Antibody directed drug targeting in cancer therapy. Targeted Drugs; (E. P. Goldberg, Ed.) pp 1-22, John Wiley and Sons, New York.
9. (d) Ram, B. P., and Tyle, P. (1987) Immunoconjugates: Applications in Targeted Drug Delivery for Cancer Therapy. Pharm. Res. 4 (3), 181-188.
10. Koppel, G. A. (1990) Recent Advances with Monoclonal Antibody Drug Targeting for the treatment of Human Cancer. Bioconjugate Chem. 1, 13-23.
11. Barton, R. L., Briggs, S. L., and Koppel, G. A. (March 1991) Monoclonal Antibody Drug Targeting. Drug News Perspect. 4 (2), 73-88.
12. (a) Gerweck, L. E., and Seetharaman, K. (1996) Cellular pH Gradient in Tumors versus Normal Tissue: Potential Exploitation for the Treatment for Cancer. Cancer Res. 56, 1194-1198.
13. (b) Lavie, E., Hirschberg, D. L., Screiber, G., Thor, G., Hill, L., Hellstrom, I., and Hellstrom, K-E. (1991) Monoclonal antibody L6-Daunomycin conjugates constructed to release free drug at lower pH tumor tissue. Cancer Immunol. Immunother. 33, 223-230.
14. Poznansky, M., and Juliano, R. L. (1984) Biological approaches to the controlled delivery of drugs: a critical review. Pharmacol. Rev. 36, 277-336.
15. (a) Shen, S. C., and Reiser, J. P. (1981) cis-Aconityl spacer between daunomycin and macromolecular carriers: Amodel of pH-sensitive linkage releasing drug from a lysosomotropic conjugate. Biochem. Biophys. Res. Commun. 102, 1048-1054.
16. (b) Yang, H. M., and Reisfeld, R. A. (1988) Doxorubicin conjugates with a monoclonal antibody directed to a human melanoma-associated proteoglycan supresses the growth of established tumor xenografts in nude mice. Proc. Natl. Acad. Sci. U.S.A. 85, 1189-1193.
17. (a) Kaneko, T., Willner, D., Monkovic, I., Knipe, J. O., Braslawsky, G. R., Greenfield, R. S., and Vyas, D. M. (1991) New hydrazone derivatives of Adriamycin and their Immunoconjugates- a correlation between acid stability and cytotoxicity. Bioconjugate Chem. 2 (3), 133-141.
18. (b) Greenfield, R. S., Kaneko, T., Duanes, A., Edson, M. A., Fitzgerald, K. A., Olech, L. J., Grattan, J. A., and Braslawsky, G. R. (1990) Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid sensitive hydrazone linker. Cancer Res. 50, 6600-6607.
19. (c) Braslawsky, G. R., Edson, M. A., Pearce, W., Kaneko, T., and Greenfield, R. S. (1990) Antitumor activity of adriamycin (hydrazone linked) immunoconjugates compared to free adriamycin and specificity of tumor cell killing. Cancer Res. 50, 6608-6614.
20. (d) Mueller, B. M., Wrasidlo, W. A., and Reisfeld, R. A. (1990) Antibody conjugates with Morpholino-doxorubicin and acid-cleavable linkers. Bioconjugate Chem. 1, 325-330.
21. Lagazza, B. C., Nicols, C. L., Briggs, S. L., Cullinan, G. J., Johnson, D. A., Starling, J. J., Baker, L. A., Bumol, T. F., and Corvalan, J. R. F. (1989) New antitumor monoclonal antibody-Vinca conjugates LY203725 and related compounds: Design, preparation, and representative in vivo activity. J. Med. Chem. 32, 548-555.
22. Srinivasachar, K., and Neville, D. M., Jr. (1989) New protein cross-linking reagents that are cleaved by mild acid. Biochemistry 28, 2501-2509.
23. Greene, T. W., Ed. (1981) Protective Groups in Organic Synthesis, pp 34-37 (hydroxy group protection), pp 273-274 (amino group protection), J. Wiley and Sons, New York.
24. Sekine, M., Iwase, R., Masuda, N., and Hata, T. (1988) Synthesis of oligoribonucleotides by use of 4,4′,4″-Tris(acyl-oxy)trityl groups for protection of 6-amino group of adenosine. Bull. Chem. Soc. Jpn. 61, 1669-1677.
25. Zikos, C. C., and Ferderigos, N. G. (1994) (R,S) 2-Fluoro (chloro) 4′-carboxy-triphenyl methanol. Novel acid labile type handles for solid phase peptide synthesis. Tetrahedron Lett. 35 (11), 1767-1768.
26. (a) Muraro, R., Wunderlich, D., Thor, A., Lundy, J., Noguchi, P., Cunningham, R., and Schlom, J. (1985) Definition by monoclonal antibodies of a repertoire of carcinembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues. Cancer Res. 45, 5769-5780.
27. (b) Kuroki, M., Greiner, J. W., Simpson, J. F., Primus, F. J., Guadagni, F., and Schlom, J. (1989) Serologic mapping and biochemical characterization of the carcinoembryonic antigen epitopes using fourteen distinct monoclonal antibodies. Int. J. Cancer 44, 208-218.
28. (c) Ikeda, S., Kuroki, M., Masahide, K., Haruno, M., Oikawa, S., Nakazato, H., Kosaki, G., and Matsuoka, Y. (1992) Epitope mapping of the carcinoembryonic antigen with various related recombinant proteins expressed in Chinese Hamster Ovary cells and 25 distinct monoclonal antibodies. Mol. Immunol. 29 (2), 229-240.
29. Starling, J., and Law, K., Lilly Research Laboratories, Indianapolis, IN, unpublished work.
30. Patel, V. F., Hertel, L. W., Grindey, G. B., Grossman, C. S., et al. (1995) Medicinal Chemistry of Difluoropurines. Seminars Oncol. 22 (4), 54-60.
31. Still, W. C., Kahn, M., and Mitra, A. J. (1978) Rapid chromatographic technique for preparative separations with moderate resolution. J. Org. Chem. 43, 2923-2925.
32. LY207702 was prepared according to the procedures of Hertel, L. W., Chou, T. S., and Jones, C. D., Lilly Research Laboratories, Indianapolis, IN, unpublished work.
33. 4. Structure-activity relationships of the lipophilic side chain. J. Med. Chem. 33, 2807-2813.
34. Harlow, E., and Lane, D. (1988) Antibodies: A laboratory manual, pp 353-355, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
35. Starling, J. J., Hinson, H. A., Marder, P., Maciak, R. S., and Laguzza, B. C. (1988) Rapid internalization of antigen-immunoconjugate complexes is not required for antitumor activity of monoclonal antibody-drug conjugates. Antibody Immunoconjug. Radiopharm. 1, 311-324.
36. Houghten, J. A., and Taylor, D. M. (1978) Maintenance of biological and biochemical characteristics of human colorectal tumors during serial passage in immune-deprived mice. Br. J. Cancer, 37, 199-212.
37. Patel, V. F., Hardin, J. N., Starling, J. J., and Mastro, J. M. (1995) Novel trityl linked drug immunoconjugates for cancer therapy. Bioorg. Med. Chem. Lett. 5 (5), 507-512.
38. Rocek, J., and Riehl, A. (1966) Concerning structural limitations in the relationship between trityl cation stability and reactivity. J. Am. Chem. Soc. 88 (20), 4747-4750.
39. Glidea, B. D., Coull, J. M., and Koster, H. (1990) A versatile acid-labile linker for modification of synthetic biomolecules. Tetrahedron Lett. 31 (49), 7095-7098.
40. Morin, C., and Vidal, M. (1992) Synthesis of a Spermidine-derived conjugating agent. Tetrahedron 48 (42), 9277-9282.
41. (a) Webb, R. R., II, and Martin, J. C. (1987) A convenient synthesis of S-HPMA. Tetrahedron Lett. 28 (42), 4963-4964.
42. (b) Kim, C. U., Luh, B. Y., and Martin, J. C. (1992) A novel synthesis of 1-Oxa-HPMPA: A potent antiviral agent against Herpesviruses. Tetrahedron Lett. 33 (1), 25-28.
43. (c) Murai, Y., Shiroto, H., Ishizaki, T., Limori, T., Kodama, Y., Ohtsuka, Y., and Oishi, T. (1992) A synthesis and X-ray analysis of 2′-C, 3′-C- and 5′-C-Methyl-sangivmycins. Heterocycles 33 (1), 391.
44. Pankiewicz, K. W., Krzeminsk, J., Ciszewski, L. A., Ren, W.-Y. and Watanabe, K. A. (1992) A synthesis of 9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine and Hypoxanthine. An effect of C3′-Endo to C2′-Endo Conformational shift on the reaction course of 2′-hydroxyl group with DSAT. J. Org. Chem. 57, 553-559.
45. Bazin, H., and Chattopadhyaya, J. (1985) A convenient preparation of 3′-Deoxyadenosine (Cordycepin) and 9-[3′(R)-Deutro-β-D-2′(R)-pentofuranosyl]-adenine. Synthesis 1108-1111.
46. Prisbe, E. J., Martin, J. C., Mcgee, P. C., Barker, M. F., Smee, D. F., Duke, A. E., Matthews, T. R., and Verheyden, J. P. H. (1986) Synthesis and antiherpes virus activity of Phosphate and Phosphonate derivatives of 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine. J. Med. Chem. 29, 671-675.
47. Reddy, M. P., Rampal, J. B., and Beaucage, S. L. (1987) An efficient procedure for the solid phase tritylation of nucleosides and nucleotides. Tetrahedron Lett. 28 (1), 23-26.
48. Patel, V. F., Hardin, J. N., Grindey, G. B., and Schultz, R. M. Tritylated oncolytics as prodrugs. Bioorg. Med. Chem. Lett. 5 (5), 513-518.
49. Bleasdale, C., Golding, B. T., Lee, W. H., Maskill, H., Riseborough, J., and Smits, E. (1994) The mechanism of deamination of Methoxy substituted tritylammonium ions in methanolic aqueous acid. J. Chem. Soc., Chem. Commun., 93-94.
50. McClelland, R. A., Banait, N., and Steenken, S. (1986) Electrophilic reactivity of the triphenylmethyl carbocation in aqueous media. J. Am. Chem. Soc. 108, 7023-7027.
51. Muraro, R., Nuti, M., Natali, P. G., Biogotti, A., Simpson, J. F., Primsus, F. J., Colcher, D., Greiner, J. W., and Schlom, J. A. (1989) A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epithelium. Int. J. Cancer 43, 598-607.
52. Hertel, L. W., Grossman, C. S., Kroin, J. S., Mineishi, S., Chubb, S., Nowak, B., and Plunkett, W. (1989) Synthesis, cytotoxicity and metabolism of the 2′,2′-Difluoroanalogs of Deoxyadenosine (dFdA) and Deoxyguanosine (dFdG). Nucleosides Nucleotides 8 (5, 6), 951-955.
53. Starling, J. J., Maciak, R. S., Hinson, N. A., Nichols, C. L., Briggs, S. L., Laguzza, B. C., Smith, W. and Corvalan, J. R. F. (1992) In vivo antitumor activity of a panel of four monoclonal antibody-Vinca alkaloid immunoconjugates which bind to three distinct epitopes of Carcinoembryonic antigen. Bioconjugate Chem. 3, 315-322.